NCT01165983
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes Type 2, +4 more
- Locations
-
- Beth Israel Deaconess Medical Center, Joslin Foot Center & Microcirculation Laboratory Boston, Massachusetts, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,001 public trials
713 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00482079
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type II, +4 more
- Locations
-
Not specified
Completed
Impact of a Program of Non-pharmacological Intervention in Patients With Type 2 Diabetes Mellitus
NCT02456064
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
NCT02946541
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Kangdong Sacred Heart Hospital Seoul, South Korea
NCT00947024
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified
NCT00773279
- Conditions
- Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
- Locations
-
- Novo Nordisk Investigational Site Burlingame, California, United States
- Novo Nordisk Investigational Site Concord, California, United States
- Novo Nordisk Investigational Site Encino, California, United States
- Novo Nordisk Investigational Site Escondido, California, United States
Completed
Italian Diabetes and Exercise Study 2
NCT01600937
- Conditions
- Behavior, Diabetes Mellitus, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- University of Rome La Sapienza, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Diabetes Unit Rome, RM, Italy
NCT01473953
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
- Locations
-
- Novo Nordisk Investigational Site Evansville, Indiana, United States
Completed
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
NCT00379769
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Miranda, New South Wales, Australia
- GSK Investigational Site Randwick, New South Wales, Australia
- GSK Investigational Site Wollongong, New South Wales, Australia
- GSK Investigational Site Carina Heights, Queensland, Australia
NCT03088670
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Non-state healthcare Organization "Road Clinical Hospital at the station Chelyabinsk Open Joint Stock Company" Russian Railways Chelyabinsk, Russia
- State Budget Healthcare Institution of Moscow "Endocrinology Dispensary" Moscow, Russia
- SEI HPE "First Moscow State Medical University n.a. I.M. Sechenov of Ministry of Health and Social Development of the Russian Federation", Chair of faculty therapy #2 based at SHI of Moscow "City clinical hospital #61" Moscow, Russia
- State Budget Educational Institution higher professional education "1st Moscow State Medical University n.a. I.M. Sechenov of the Ministry of Healthcare of Russian Federation" Moscow, Russia